Immunotherapy has been one of the breakthroughs in cancer treatment. Using innate and adaptive immune responses to control tumors has yielded efficacies in many patients. Yet the questions remain as to what can be the best targets for treatment, and why some patients resist to the therapy.
In this webinar, you will learn how single-cell RNA sequencing can come in handy to help answer such questions and enrich our knowledge of the antitumor immunity.
- How single-cell analysis can help advance our understanding of the antitumor immunity
- Emergent analytical approaches
Anthony Cillo, PhD
UPMC Hillman Post-Doctoral Fellow for Innovative Cancer Research, University of Pittsburgh